Tregs can suppress effector T cell functions, such as those of CD8 + T cells, by secreting inhibitory cytokines like IL-10 and TGF-β and through direct cell interactions, thereby impairing their ability to recognize and eliminate tumour cells [77–79]. The gene discussed is TGFB1; the disease is neoplasm.